Apoptosis Antagonizing Transcription Factor (AATF) Peptide
AATF
Reactivité: Humain, Singe
Hôte: Synthetic
BP
-
- Antigène Tous les produits AATF
- AATF (Apoptosis Antagonizing Transcription Factor (AATF))
- Origine
- Humain, Singe
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-AATF Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- AATF (Apoptosis Antagonizing Transcription Factor (AATF))
- Synonymes
- AATF Peptide, ded Peptide, che1 Peptide, che-1 Peptide, cb109 Peptide, sb:cb109 Peptide, wu:fc13d05 Peptide, zgc:162071 Peptide, CHE-1 Peptide, CHE1 Peptide, DED Peptide, 4933415H02Rik Peptide, 5830465M17Rik Peptide, Che-1 Peptide, Trb Peptide, Ded Peptide, apoptosis antagonizing transcription factor Peptide, Apoptosis antagonizing transcription factor Peptide, apoptosis antagonizing transcription factor S homeolog Peptide, AATF Peptide, aatf Peptide, BFR2 Peptide, NAEGRDRAFT_56916 Peptide, Aatf Peptide, aatf.S Peptide
- Sujet
- CHE1, DED, Protein AATF, Apoptosis-antagonizing transcription factor, Rb-binding protein Che-1
- ID gène
- 26574
- UniProt
- Q9NY61
-
Vous êtes ici:
